Está en: Publicaciones
Bibliografía Científica
Introduce tu nombre   primer Apellido   segundo Apellido Teléfono   e-mail   País   Comentarios
He leído y acepto el aviso legal.*


Bibliografía científica sobre inmunoterapia activa en el tratamiento del cáncer.

Publicaciones en Castellano

  1. Bases moleculares de la inmunología del cáncer leer más...
  2. Vacunas y cáncer cervicouterino: leer más...
  3. Inmunoterapia activa en el tratamiento de neoplasias hematológicas: leer más...
  4. Avances en inmunoterapia celular contra el melanoma maligno: leer más...
  5. Uso de diferentes combinaciones de inmunoterapia en pacientes: leer más...
  6. Nuevas tendencias en inmunoterapia para el cáncer de próstata MINIREVIEW: leer más...
  7. Inmunoterapia activa en cáncer de próstata: Revisión con atención especial a las células dendríticas: leer más...
  8. Inmunoterapia celular contra el cáncer: leer más...
  9. Vacunas terapéuticas en cáncer. Ensayos clínicos actuales: leer más...
  10. Inmunoterapia del cáncer: Importancia de controlar la inmunosupresión: leer más...
  11. Vacunas y cáncer de mama: leer más...

Publicaciones en Inglés

  1. Pardoll DM. Cancer immunology. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, editors. Abeloff's Clinical Oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008.
  2. Murphy KM, Travers P, Walport M, editors. Janeway's Immunobiology. 7th ed. New York: Garland Science, 2007.
  3. Waldmann TA. Effective cancer therapy through immunomodulation. Annual Review of Medicine 2006; 57:65–81. [PubMed Abstract]
  4. Emens LA. Cancer vaccines: on the threshold of success. Expert Opinion on Emerging Drugs 2008; 13(2):295–308. [PubMed Abstract]
  5. Sioud M. An overview of the immune system and technical advances in tumor antigen discovery and validation. Methods in Molecular Biology 2007; 360:277–318. [PubMed Abstract]
  6. Pazdur MP, Jones JL. Vaccines: an innovative approach to treating cancer. Journal of Infusion Nursing 2007; 30(3):173–178. [PubMed Abstract]
  7. Lollini PL, Cavallo F, Nanni P, Forni G. Vaccines for tumour prevention. Nature Reviews Cancer 2006; 6(3):204–216. [PubMed Abstract]
  8. Frazer IH, Lowy DR, Schiller JT. Prevention of cancer through immunization: prospects and challenges for the 21st century. European Journal of Immunology 2007; 37(Suppl 1):S148–S155. [PubMed Abstract]
  9. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clinical Science 2006; 110(5):525–541. [PubMed Abstract]
  10. Parkin DM. The global health burden of infection-associated cancers in the year 2002. International Journal of Cancer 2006; 118(12):3030–3044. [PubMed Abstract]
  11. Lowy DR, Schiller JT. Prophylactic human papillomavirus vaccines. Journal of Clinical Investigation 2006; 116(5):1167–1173. [PubMed Abstract]
  12. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: immunization of infants, children, and adolescents. Morbidity and Mortality Weekly Report 2005; 54(No. RR–16):1–31. [PubMed Abstract]
  13. Mueller NE. Cancers caused by infections: unequal burdens. Cancer Epidemiology, Biomarkers & Prevention 2003; 12(3):237s. [PubMed Abstract]
  14. International Agency for Research on Cancer (2011). Agents Classified by the IARC Monographs , Volumes 1–100. Retrieved November 15, 2011.
  15. Rivoltini L, Canese P, Huber V, et al. Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control? Expert Opinion on Biological Therapy 2005; 5(4):463–476. [PubMed Abstract]
  16. Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nature Medicine 2004; 10(9):909–915. [PubMed Abstract]
  17. Renkvist N, Castelli C, Robbins PF, Parmiani G. A listing of human tumor antigens recognized by T cells. Cancer Immunology and Immunotherapy 2001; 50(1):3–15. [PubMed Abstract]
  18. Parmiani G, Russo V, Marrari A, et al. Universal and stemness-related tumor antigens: potential use in cancer immunotherapy. Clinical Cancer Research 2007; 13(19):5675–5679. [PubMed Abstract]
  19. Kantoff PW, Higano CS, Shore ND, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. New England Journal of Medicine 2010; 363(5):411–422. [PubMed Abstract]
  20. Parmiani G, De Filippo A, Novellino L, Castelli C. Unique human tumor antigens: immunobiology and use in clinical trials. The Journal of Immunology 2007; 178(4):1975–1979. [PubMed Abstract]
  21. Finn OJ. Cancer immunology. The New England Journal of Medicine 2008; 358(25):2704–2715. [PubMed Abstract]
  22. Curigliano G, Spitaleri G, Dettori M, et al. Vaccine immunotherapy in breast cancer treatment: promising, but still early. Expert Review of Anticancer Therapy 2007; 7(9):1225–1241. [PubMed Abstract]
  23. Chiarella P, Massi E, De Robertis M, Signori E, Fazio VM. Adjuvants in vaccines and for immunisation: current trends. Expert Opinion on Biological Therapy 2007; 7(10):1551–1562. [PubMed Abstract]
  24. Herr HW, Morales A. History of Bacillus Calmette-Guérin and bladder cancer: an immunotherapy success story. The Journal of Urology 2008; 179(1):53–56. [PubMed Abstract]
  25. Emens LA. Chemotherapy and tumor immunity: an unexpected collaboration. Frontiers in Bioscience 2008; 13:249–257. [PubMed Abstract]
  26. Schlom J, Arlen PM, Gulley JL. Cancer vaccines: moving beyond current paradigms. Clinical Cancer Research 2007; 13(13):3776–3782. [PubMed Abstract]
  27. Ng LG, Mrass P, Kinjyo I, Reiner SL, Weninger W. Two-photon imaging of effector T-cell behavior: lessons from a tumor model. Immunological Reviews 2008; 221:147–162. [PubMed Abstract]
  28. Garnett CT, Greiner JW, Tsang KY, et al. TRICOM vector based cancer vaccines. Current Pharmaceutical Design 2006; 12(3):351–361. [PubMed Abstract]
  29. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nature Reviews Immunology 2006; 6(4):295–307. [PubMed Abstract]
Capistran © 2012 | Aviso legal | desarrollado por dinamiq
teléfonos:902 585 540 | 628 308 308

Doctor Capistran lucha contra el cancer a través de la nueva terapia alternativa, los avances contra el cancer se ven reflejados gracias a la medicina natural basada en los antígenos de las Orina.